- Increasingly stringent emissions regulations requiring cost-intensive retrofitting of Loba's production facilities.
- Significant increase in electricity consumption due to the conversion of Loba into a modern biotech site.
- Stricter regulatory requirements for environmental protection and hazardous materials.
- Potential for reputational damage from environmental pollution.
pharmaand GmbH
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, pharmaand GmbH disclosed greenhouse gas emissions of 2.2K tCO2e/year. By scope: Scope 1: 1.8K tCO2e/year; Scope 2: 49.9 tCO2e/year; Scope 3: 153.95 tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
2.2K tCO2e/year
2023
Waste
192.14 tons/year
2023
Energy Use
3.6K MWh/year
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 1.8K tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 49.9 tCO2e/year |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 153.95 tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
📈 Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2023 | 2.2K tCO2e/year |
| 2022 | 1.4K tCO2e/year |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
✅ Reported Environmental Achievements
- Offset all CO2 emissions for 2023 with certificates from Climate Austria.
- Contracted with Energie Klagenfurt GmbH for green electricity supply to Loba, significantly reducing GHG emissions.
- Planned installation of a 152 kWp photovoltaic system and a 56 kW hydropower plant at Loba in 2024, aiming to increase renewable energy share to 55%.
- Reduced volatile organic compounds (VOC) in Loba's production exhaust air to 300 kg (from 868 kg in 2022).
🎯 Climate & Sustainability Targets
🔜 Short-term
- Complete the test phase of biopharmaceutical production and begin engineering runs by Q2 2024.
- Implement the assessment of mental stress in the workplace in 2024.
- Develop an e-learning platform for Loba Academy.
📅 Medium-term
- Achieve 55% renewable energy share at Loba with the PV and hydropower plants.
🌱 ESG Focus Areas
Climate protectionEnvironmental pollutionSustainable supply chainWorkplace health and safetyAttractive, diverse and family-friendly employerCorporate governance and complianceCombating bribery and corruptionProduct safety and qualityHealth for allPatient centering